Doxazosin for the treatment of nightmare disorder: A diary-based case study.
SAGE open medical case reports 2020 Ståle Pallesen, Hilde Sofie Hamre, Nina Lang et al.
The α1-adrenergic antagonist prazosin has showed good effect against posttraumatic stress disorder-related nightmares in several randomized controlled trials. The α1-adrenergic antagonist doxazosin, which has a longer half-live than prazosin, has received far less attention in the treatment of such nightmares. Here, we report a case of a patient suffering from severe nightmares following an...
DOI: 10.1177/2050313x20936079 (opens in new tab)
Full text (opens in new tab)
Doxazosin
Nightmare disorder
Treatment
Α1-adrenergic antagonist